News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Discover Latest #Financial support News, Articles and Videos with Contenting
1. "Fintech Funding Hits Record High in 2020, Thanks to Coronavirus Stimulus" - CNBC, December 28, 2020 https://www.cnbc.com/2020/12/28/fintech-funding-hits-record-high-in-2020-thanks-to-coronavirus-stimulus.html 2. "These Are the Government Programs That Can Provide Financial Support to Small Businesses During the Coronavirus Crisis" - Forbes, April 3, 2020 https://www.forbes.com/sites/alexkonrad/2020/04/03/these-are-the-government-programs-that-can-provide-financial-support-to-small-businesses-during-the-coronavirus-crisis/ 3. "Coronavirus: What is the Job Support Scheme and how do I claim financial support?" - The Independent, October 13, 2020 https://www.independent.co.uk/money/coronavirus-job-support-scheme-claim-furlough-self-employed-a9670096.html 4
Budget 2025 Expectations Live: ICEA calls for ₹40,000 crore financial support from government for electronics manufacturing - The Hindu BusinessLine
India Union Budget 2025, Budget 2025-26 Expectations Live Updates: The Union Budget for 2025-26 will be presented by Finance Minister Nirmala Sitharaman on February 1, 2025. Budget announcements will gain importance as it comes in the middle of what observers call a cyclical slowdown for the Indian economy. Consumption spending is slowing as has capital expenditure, both private and public. Industry captains will look for signs of a step up in government capital spending.
BellaSeno Successfully Completes Two Clinical Trials with Novel, Resorbable Breast Implants - ForexTV
One-year follow-up data confirm favorable safety profile of BellaSeno´s scaffolds compared to silicone implantsCompany plans expansion to primary breast augmentation and lumpectomy Leipzig, Germany/ Brisbane, Australia, January 14, 2025 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, today announced that all 19 breast scaffold patients enrolled in 2022 in an Australian breast augmentation revision trial have successfully completed a one-year follow-up without any major scaffold-related complications or scaffold removals. In addition, in a parallel Australian clinical trial, 7 pectus excavatum patients have successfully passed one-year follow-up. The trials are the first-ever implant trials using a novel approach combining polycaprolactone (PCL) scaffolds, ultimately resulting in a fully resorbed implant and natural tissue. The data show that it is possible to replace silicone implants in breast augmentation with alternatives offering improved safety and quality of life. The trials are sponsored, single-arm, open, mono-centric, interventional, prospective clinical investigation studies in patients requiring breast augmentation revisions or surgical pectus excavatum correction. Primary endpoint is post-operative device safety, secondary endpoints is post-operative patient safety and post-operative device performance (QOL, volume replacement). The one-year assessment confirms a very favorable safety profile of BellaSeno´s resorbable soft tissue implants. No major complications such as capsular contracture, calcifications, oil cysts, infections, tissue necrosis, or wound healing issues were observed. No scaffold removals or replacements were necessary, and no scaffold-related complications were observed in any patients six months post-surgery. The one-year data review by the Independent Data Safety Monitoring Committee stated that all adverse events were within the expected range of complications for removal / replacement surgeries. The Clinical Investigators reported higher patient satisfaction with breasts and quality of life associated with BellaSeno´s scaffolds compared to baseline (i.e. silicone implants). There was high acceptability; patients were pain-free and did not report awareness of the scaffold in situ after twelve months. Identical findings were made in the one-year follow up in pectus excavatum patients. “This is a very encouraging one-year clinical outcome,” said Mohit Chhaya, CEO of BellaSeno. “The data confirm that our resorbable scaffolds do not only meet the desired safety criteria but also show an improvement of patients´ quality of life. We now have a very strong clinical data set to initiate a pivotal study of our resorbable breast scaffolds in the U.S. and Europe. We will also expand the use of our scaffolds to primary breast augmentation and lumpectomy and also provide a final two-year follow-up next year.” ### About BellaSenoBellaSeno GmbH was founded in 2015 and is headquartered on the BioCity campus in Leipzig, Germany, with a subsidiary in Brisbane, Australia. The Company is developing novel resorbable soft tissue and bone reconstruction implants made by additive manufacturing (3D-printing) under ISO 13485 certification. The Company has received substantial financial support from private investors as well as from the Saxony Development Bank (SAB), the European Fund for Regional Development (EFRE), Germany´s Federal Ministry of Education and Research (BMBF) and the Australian government. The Company has been co-funded from tax resources based on the budget adopted by the members of Saxony State Parliament. Contact BellaSenoBellaSeno GmbHDr. Mohit Chhayamohit.chhaya@bellaseno.comTel.: +49 176 2283 9583 Media InquiriesakampionDr. Ludger Wess / Ines-Regina Buth Managing Partnersinfo@akampion.comTel. +49 40 88 16 59 64Tel. +49 30 23 63 27 68
Donation vexation: FTC and 10 States challenge cancer “charity” as a sham | Federal Trade Commission
Think about the two women across from you in the office. Now consider the sobering statistic that of those two women, one will battle cancer in her lifetime. The bad news gets worse when you realize there are sham charities out there that claim to offer financial assistance for people undergoing cancer treatment, but then spend donations for other purposes. The FTC and 10 states just sued Cancer Recovery Foundation International (also known as Women’s Cancer Fund) and Gregory B. Anderson, alleging the defendants collected $18 million from generous Americans between 2017 and 2022 while providing only $194,809 in financial support for cancer patients – literally about a penny of every donated dollar. According to the lawsuit, Anderson pocketed $775,139, nearly four times more than what the “charity” gave collectively to women battling cancer. But hold on to your hat – and your wallet – when you learn where the FTC and the States say the rest of the money went.
View: Budget 2025, a much-needed shot of growth hormones - The Economic Times
The budget promotes key sectors including healthcare, R&D, skilling, MSMEs, and startups, laying groundwork for economic growth. Key measures involve exempting customs duty on life-saving drugs, investment in private-sector R&D, and financial support for startups. Concerns arise about healthcare spending targets, yet advancements in insurance and regulatory reforms aim to enhance accessibility and affordability.
Union Budget 2025: 3 CoEs to help India position itself as a global powerhouse in AI | Zee Business
To unleash this potential, it is also important to offer financial support and streamline the process of conducting business to bolster the startup community. The Fund of Funds for Startups (FFS) will provide the impetus to boost this ecosystem, she mentioned. Get more India News and Business News on Zee Business.
Hemlo Explorers Announces Change in Management and Name Change to Rocky Shore Gold Ltd. - ForexTV
TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Hemlo Explorers Inc. (the “Company”) (CSE: HMLO) is pleased to announce that, following the shareholder’s meeting held on January 30, 2025, Ken Lapierre has been appointed as President and Chief Executive Officer, effective February 1, 2025. Concurrently, Brian Howlett, the former Chief Executive Officer, has been appointed Chairman of the Board of Directors. Mr. Brian Howlett commented, “It has been my honour to serve as CEO of Hemlo Explorers Inc. for the past four years, and I am excited to be moving ahead with our Gold Anchor project in Newfoundland. I look forward to working with Ken in developing Gold Anchor towards discovery.” Ken Lapierre added, “I look forward to this exciting challenge as President and CEO of Hemlo Explorers, which is soon to be Rocky Shore Gold. Our new mission is to explore our Gold Anchor Project for the next major Newfoundland gold deposit located in a new emerging gold district with proven high grade gold discoveries. I thank our shareholders, Brian, the Board of Directors and our largest shareholder (Rob Cudney and Northfield Capital) as we embark on this truly exciting opportunity.” Mr. Lapierre is a professional geologist and financier with over 40 years in the precious and base metals business. He previously was the founder of, and spent seventeen years with, Rockcliff Metals Corporation, holding various senior roles, including President, CEO and VP of Exploration. He was involved in all aspects of the company including finance, exploration, discovery, growth of resources and the eventual sale of Rockcliff to Hudbay Minerals Inc. Mr. Lapierre began his career as an exploration and mine geologist where he worked in grass roots to mine development scenarios. He founded several junior exploration companies raising more than CAD$175M for company growth and advancement. He was founder and VP Exploration of junior explorer Mustang Minerals (now Grid Metals), founder, President, CEO and VP Exploration of JML Resources (acquired by Aquiline Resources), and founder, President, CEO and VP Exploration of Tyranex Gold and Findore Minerals. He holds an Honours Science Degree in Geology from the University of Western Ontario (now Western University) and is a Professional Geoscientist in good standing with the Association of Professional Geoscientists of Ontario. Name Change to Rocky Shore Gold Ltd. The Company is also pleased to announce that it will change its name to “Rocky Shore Gold Ltd.” (the “Name Change”). The Company’s common shares are expected to commence trading on the Canadian Securities Exchange (the “CSE”) under its new name and new trading symbol “RSG” at the opening of trading on February 10, 2025. The new CUSIP will be 774917108 and the new ISIN will be CA7749171087. There is no change to the share capital of the Company. The Company anticipates no interruptions to its trading activities as part of this change. Shareholders are not required to take any action concerning the name and ticker symbol change, which will be automatically updated on all relevant trading platforms. A copy of the certificate and articles of amendment evidencing the change of name will be filed on SEDAR+ in due course. The Name Change remains subject to the approval of the CSE. About Hemlo Explorers Inc. Hemlo is a well funded Canadian-based mineral exploration company with a focus to discover the next major gold deposit in Newfoundland, Canada. Hemlo is focused on advancing its flagship 100% controlled Gold Anchor Project in central Newfoundland. The project totals over 1,250 square kilometres (approximately 70 km long by 20 km wide) in an emerging gold district. It is strategically located immediately southwest of and on trend to significant high grade gold discoveries. Gold Anchor represents an excellent opportunity for the discovery of multiple gold systems in a significantly underexplored area of central Newfoundland. Hemlo is also advancing its Pic Project (optioned to Barrick Gold inc.), and investigating opportunities to monetize Projects Idaho and the North Limb near Marathon, Ontario. Hemlo would like to acknowledge the financial support of the Junior Exploration Assistance Program from the Department of Natural Resources, Government of Newfoundland and Labrador. For more information please contact: Ken Lapierre, President & CEO Hemlo Explorers Inc.klapierrede73@gmail.com1-647-678-3879 Brian Howlett, ChairmanHemlo Explorers Inc.brian@hemloexplorers.ca 1-647-227-3035 http://www.hemloexplorers.ca Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian and United States securities laws. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur”, or “be achieved”. Certain information set forth in this news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties, including, but not limited to the advancement of the Company’s properties, the anticipated closing date of the Name Change and the approval of the CSE. The forward-looking information is based on reasonable assumptions and estimates of the management of the Company at the time such statements were made and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Hemlo to be materially different from those expressed or implied by such forward-looking information, including risks associated with the exploration; future commodity prices; changes in regulations; political or economic developments; environmental risks; permitting timelines; capital expenditures; technical difficulties in connection with exploration activities; employee relations; the speculative nature of mineral including the risks of diminishing quantities of grades of resources, contests over title to properties, the Company’s limited operating history, future capital needs and uncertainty of additional financing, and the competitive nature of the mining industry; the need for the Company to manage its future strategic plans; global economic and financial market conditions; uninsurable risks; and changes in project parameters as plans continue to be evaluated. Although Hemlo has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Although the forward-looking information contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, Hemlo cannot assure shareholders that actual results will be consistent with such forward-looking information, as there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. Hemlo does not undertake any obligations to release publicly any revisions for updating any voluntary forward-looking information, except as required by applicable securities law. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Supporting Independent Films and Art Through Crowdfunding - TechBullion
Independent films and art projects often struggle to find financial backing. Unlike mainstream productions, these projects lack corporate funding or big studio investments. Crowdfunding has emerged as a powerful tool, giving creators the financial support they need. It allows artists and filmmakers to connect directly with their audiences and secure funding from passionate supporters. The […]